Value-based care has largely won the policy debate in American healthcare. Across Medicare, Medicaid, Medicare Advantage, and commercial insurance, payment models increasingly tie reimbursement to quality, outcomes, and total cost of care rather than volume of services. Participation in alternative payment models is no longer experimental or optional for many organizations, as it’s often embedded in contracts, strategy, and financial planning
